3177 results for «321»

Filter By

3177 results

Acute and chronic right ventricular failure: focus on the weak link

16 May 2024 – From EuroPCR 2024

This session discusses new diagnostic and therapeutic aspects of shock due to right ventricular infarction, explores why and how the failing right ventricle contributes to worsening heart failure, and examines device-based treatment opportunities for chronic right ventricular and tricuspid valve failure, including repair vs replacement. It...

Acute and chronic right ventricular failure: focus on the weak link

New evidence on TAVI from PCR Companions

17 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable...

New evidence on TAVI from PCR Companions

Imaging and physiology guided PCI

17 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 clinical case submissions showcasing the use of imaging and physiology guidance during PCI. Cases cover topics such as managing cardiac arrest during PCI, virtual reality-guided PCI, low-contrast PCI in multivessel disease, and the comprehensive assessment of obstructive and non-obstructive coronary...

Imaging and physiology guided PCI

Acute coronary syndromes: keep an eye open for unusual presentations

17 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 clinical case submissions highlighting unusual presentations of acute coronary syndromes. Cases cover topics such as a "ring" completing the "crown", recurrent vasospastic angina culminating in STEMI, myocardial infarction of unusual cause, and primary PCI in dextrocardia. Discussions emphasize the importance...

Acute coronary syndromes: keep an eye open for unusual presentations

Update on coronary physiology in 2024

17 May 2024 – From EuroPCR 2024

This session provides an update on the available options for invasive coronary physiology in 2024. It reviews the latest evidence supporting the clinical adoption of invasive physiology indexes and shares practical tips and tricks for their application. Topics covered include CT-based physiology, pressure wire-based physiology, angiography-based...

Update on coronary physiology in 2024

Personalised Vascular Care Award ceremony

16 May 2024 – From EuroPCR 2024

This session is the Personalised Vascular Care Award ceremony, sponsored by Abbott. The objectives and details of this session are not provided, as it is likely an event to recognize and celebrate achievements in the field of personalized vascular care.

Personalised Vascular Care Award ceremony

Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024

17 May 2024 – From EuroPCR 2024

Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.

References

  • SOLVE-TAVI: Feistritzer HJ, et al....
EuroPCR 2024 Scientific highlights, clinical trial updates and key learnings

EAPCI Fellowship Grants Award Ceremony

16 May 2024 – From EuroPCR 2024

This session is the EAPCI Fellowship Grants Award Ceremony, where outstanding individuals will be recognized for their contributions to the field of interventional cardiology.

EAPCI Fellowship Grants Award Ceremony

EuroPCR 2024 Best Abstract and Best Clinical Case Award ceremony

17 May 2024 – From EuroPCR 2024

This session is the award ceremony for the best abstract and best clinical case presented at EuroPCR 2024. The winners will be announced and recognized for their outstanding contributions to the field of interventional cardiology.

Best Abstract and Best Clinical Case Award ceremony

Tribute to Alain Cribier

14 May 2024 – From EuroPCR 2024

Tribute to Alain Cribier

Michele Pighi Young Investigator Award ceremony

15 May 2024 – From EuroPCR 2024

This session is dedicated to the presentation of the Michele Pighi Young Investigator Award, recognizing and celebrating the achievements of young researchers and clinicians in the field of interventional cardiology.

Michele Pighi Young Investigator Award ceremony

Andreas Grüntzig Ethica Award ceremony

15 May 2024 – From EuroPCR 2024

This session is the Andreas Grüntzig Ethica Award ceremony.

Andreas Grüntzig Ethica Award ceremony

BYPASS-CTCA: The value of computed tomography cardiac angiography in improving patient satisfaction and reducing contrast load, procedural duration and complications in patients who had previous CABG undergoing invasive coronary angiography

19 Sep 2022

Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.

It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.

Nicola Ryan

Author

Nicola Ryan
Trial Computed Tomography Cardiac Angiography Contrast Load Procedural Duration CABG Invasive Coronary Angiography

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

29 Mar 2025

Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.

Author

Ali Nazmi Calik
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?